J9202 Goserelin acetate implant
Also known as: goserelin, Zoladex
Subcutaneous implant of goserelin acetate, a gonadotropin-releasing hormone (GnRH) agonist.
In Plain Language
testosterone-lowering prostate cancer treatment; hormone pellet
Clinical Context
Used for advanced prostate cancer and breast cancer as long-acting subcutaneous implant.
RVU Information
CPT J9202 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9202?
CPT J9202 (Goserelin acetate implant) is a J Codes (Drugs) code. Subcutaneous implant of goserelin acetate, a gonadotropin-releasing hormone (GnRH) agonist.
How is J9202 administered?
CPT J9202 is administered by a healthcare provider, typically via injection or infusion. Used for advanced prostate cancer and breast cancer as long-acting subcutaneous implant. It is used by Urology, Oncology.
When is CPT J9202 used?
Used for advanced prostate cancer and breast cancer as long-acting subcutaneous implant.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.